Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2361]

The enhancing oncology model and other value-based propositions

Dr Kelly King - Memorial Healthcare System, Florida, USA

The enhancing oncology model and other value-based propositions ( Dr Kelly King - Memorial Healthcare System, Florida, USA )

Breast cancer and survivorship

Dr Ashwin Mehta - Memorial Healthcare System, Florida, USA

Breast cancer and survivorship ( Dr Ashwin Mehta - Memorial Healthcare System, Florida, USA )

Challenges in interpreting comprehensive biomarker testing and a few paths to...

Dr Howard Jack West - City of Hope Comprehensive Cancer Center, California, USA

Challenges in interpreting comprehensive biomarker testing and a few paths to address them ( Dr Howard Jack West - City of Hope Comprehensive Cancer Center, California, USA )

Addressing cancer disparities in Hispanic populations in the US and in low and...

Dr Luis Raez and Dr Eduardo Cazap

Addressing cancer disparities in Hispanic populations in the US and in low and middle income countries ( Dr Luis Raez and Dr Eduardo Cazap )

Liquid biopsies and cancer: The role of NGS, CTC, exosomes, cfDNA and cfRNA

Dr Bruna Pellini - Moffitt Cancer Center, Tampa, USA

Liquid biopsies and cancer: The role of NGS, CTC, exosomes, cfDNA and cfRNA ( Dr Bruna Pellini - Moffitt Cancer Center, Tampa, USA )

Updates in melanoma and skin cancers

Dr Sanjiv Agarwala - St. Luke’s Cancer Center, Philadelphia, USA

Updates in melanoma and skin cancers ( Dr Sanjiv Agarwala - St. Luke’s Cancer Center, Philadelphia, USA )

Gynaecological cancer: New targets and immunotherapy developments

Dr Mark Shahin - Jefferson Health, Philadelphia, USA

Gynaecological cancer: New targets and immunotherapy developments ( Dr Mark Shahin - Jefferson Health, Philadelphia, USA )

Molecular oncology and translational medicine

Dr Gregg Fields - Florida Atlantic University, Florida, USA

Molecular oncology and translational medicine ( Dr Gregg Fields - Florida Atlantic University, Florida, USA )

Potential benefit to response rates from trastuzumab added to perioperative...

Dr Anna Wagner - The University of Lausanne, Lausanne, Switzerland, Co-chair of...

Potential benefit to response rates from trastuzumab added to perioperative chemotherapy for patients with HER-2+ GC ( Dr Anna Wagner - The University of Lausanne, Lausanne, Switzerland, Co-chair of the EORTC Gastric Cancer Task Force )

Rationale for routine use of IORT for early breast cancer and data for specific...

Dr Hans-Christian Kolberg - Marienhospital Bottrop gGmbH, Bottrop, Germany

Rationale for routine use of IORT for early breast cancer and data for specific indications ( Dr Hans-Christian Kolberg - Marienhospital Bottrop gGmbH, Bottrop, Germany )

The role of provider assumptions in decreasing access to care in the LGBTQ...

Dr Narjust Flores - Dana-Farber Cancer Institute, Boston, USA

The role of provider assumptions in decreasing access to care in the LGBTQ community ( Dr Narjust Flores - Dana-Farber Cancer Institute, Boston, USA )

Cancer and Suicide Risk in SGM Population

Dr Gadoberto Solano - Caja Costarricense del Seguro Social, Costa Rica

Cancer and Suicide Risk in SGM Population ( Dr Gadoberto Solano - Caja Costarricense del Seguro Social, Costa Rica )

More from ecancer